Compagnie Lombard Odier SCmA - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$23,660
-39.2%
14,0000.0%0.00%0.0%
Q2 2023$38,920
+52.7%
14,0000.0%0.00%0.0%
Q1 2023$25,480
-64.1%
14,0000.0%0.00%
-50.0%
Q4 2022$71,000
+1.4%
14,0000.0%0.00%0.0%
Q3 2022$70,000
+34.6%
14,0000.0%0.00%
+100.0%
Q2 2022$52,000
-34.2%
14,0000.0%0.00%
-50.0%
Q1 2022$79,00014,0000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders